Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | decreases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | epigallocatechin gallate results in decreased expression of CCDC167 mRNA | CTD | PMID:22079256 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCDC167 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Ccdc167 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCDC167 mRNA | CTD | PMID:36331819 | (S)-nicotine | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Nicotine results in increased expression of CCDC167 mRNA | CTD | PMID:23825647 | 1,1-dichloroethene | increases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of CCDC167 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | multiple interactions | ISO | Ccdc167 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCDC167 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CCDC167 mRNA | CTD | PMID:32145629 | 2-hydroxypropanoic acid | affects expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Lactic Acid affects the expression of CCDC167 mRNA | CTD | PMID:30851411 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA | CTD | PMID:28628672 | 5-aza-2'-deoxycytidine | affects expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Decitabine affects the expression of CCDC167 mRNA | CTD | PMID:23300844 | Aflatoxin B2 alpha | decreases methylation | ISO | CCDC167 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of CCDC167 intron | CTD | PMID:30157460 | aristolochic acid A | decreases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CCDC167 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to CCDC167 mRNA] | CTD | PMID:32406909 | avobenzone | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | avobenzone results in increased expression of CCDC167 mRNA | CTD | PMID:31016361 | benzo[e]pyrene | increases methylation | ISO | CCDC167 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of CCDC167 intron | CTD | PMID:30157460 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of CCDC167 mRNA | CTD | PMID:26496021 | bisphenol A | decreases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CCDC167 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CCDC167 mRNA | CTD | PMID:30816183 more ... | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCDC167 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA | CTD | PMID:28628672 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CCDC167 mRNA | CTD | PMID:33453195 | carbon nanotube | increases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of CCDC167 mRNA | CTD | PMID:25554681 and PMID:25620056 | carbon nanotube | decreases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of CCDC167 mRNA | CTD | PMID:25554681 | cisplatin | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CCDC167 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of CCDC167 mRNA | CTD | PMID:27392435 | cisplatin | affects expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Cisplatin affects the expression of CCDC167 mRNA | CTD | PMID:23300844 | copper(II) sulfate | decreases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CCDC167 mRNA | CTD | PMID:19549813 | coumestrol | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of CCDC167 mRNA | CTD | PMID:19167446 | crocidolite asbestos | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in increased expression of CCDC167 mRNA | CTD | PMID:29523930 | cyclosporin A | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CCDC167 mRNA | CTD | PMID:20106945 more ... | dexamethasone | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA | CTD | PMID:28628672 | diquat | decreases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | Diquat results in decreased expression of CCDC167 protein | CTD | PMID:36851058 | disodium selenite | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of CCDC167 mRNA | CTD | PMID:18175754 | diuron | decreases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Diuron results in decreased expression of CCDC167 mRNA | CTD | PMID:35967413 | folic acid | multiple interactions | ISO | Ccdc167 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCDC167 mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | ISO | CCDC167 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CCDC167 protein | CTD | PMID:37730182 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of CCDC167 mRNA | CTD | PMID:24136188 | indometacin | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA | CTD | PMID:28628672 | methapyrilene | increases methylation | ISO | CCDC167 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of CCDC167 intron | CTD | PMID:30157460 | nickel atom | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Nickel results in increased expression of CCDC167 mRNA | CTD | PMID:25583101 | nickel sulfate | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of CCDC167 mRNA | CTD | PMID:22714537 | nicotine | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Nicotine results in increased expression of CCDC167 mRNA | CTD | PMID:23825647 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ccdc167 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCDC167 mRNA | CTD | PMID:36331819 | potassium chromate | multiple interactions | ISO | CCDC167 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCDC167 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CCDC167 mRNA | CTD | PMID:22079256 | rac-lactic acid | affects expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Lactic Acid affects the expression of CCDC167 mRNA | CTD | PMID:30851411 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of CCDC167 mRNA | CTD | PMID:26496021 | testosterone | multiple interactions | ISO | Ccdc167 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:33848595 | testosterone | decreases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of CCDC167 mRNA | CTD | PMID:33848595 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CCDC167 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CCDC167 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Ccdc167 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CCDC167 mRNA | CTD | PMID:23557971 and PMID:27760801 | tunicamycin | decreases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of CCDC167 mRNA | CTD | PMID:22378314 | valproic acid | increases expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CCDC167 mRNA | CTD | PMID:23179753 and PMID:28001369 | valproic acid | affects expression | ISO | CCDC167 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CCDC167 mRNA | CTD | PMID:25979313 | |